home / stock / iva / iva articles

IVA Articles, Inventiva S.A. - From 11/06/23

Stock Information
Company Name: Inventiva S.A.
Stock Symbol: IVA
Market: NASDAQ
Website: inventivapharma.com
Menu
IVA IVA Quote IVA Short IVA News IVA Articles IVA Message Board
Get IVA Alerts

News, Short Squeeze, Breakout and More Instantly...
Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023 | Benzinga

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. Two additional sc...
Inventiva reports its 2023 first-half financial results and provides a corporate update | Benzinga

Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million1, and long-term deposit at €9.3 million2, as of June 30, 2...

Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease | Benzinga

Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar...

Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea | Benzinga

Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position.   Under the exclusive lice...
Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty certificates | Benzinga

Daix (France), Long Island City (New York, United States), August 31, 2023 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharma...

Previous 10 Next 10